Fungal microbiome in inflammatory bowel disease: a critical assessment

J Clin Invest. 2022 Mar 1;132(5):e155786. doi: 10.1172/JCI155786.

Abstract

The gut microbiome is at the center of inflammatory bowel disease (IBD) pathogenesis and disease activity. While this has mainly been studied in the context of the bacterial microbiome, recent advances have provided tools for the study of host genetics and metagenomics of host-fungal interaction. Through these tools, strong evidence has emerged linking certain fungal taxa, such as Candida and Malassezia, with cellular and molecular pathways of IBD disease biology. Mouse models and human fecal microbial transplant also suggest that some disease-participatory bacteria and fungi may act not via the host directly, but via their fungal-bacterial ecologic interactions. We hope that these insights, and the study design and multi-omics strategies used to develop them, will facilitate the inclusion of the fungal community in basic and translational IBD research.

Publication types

  • Review

MeSH terms

  • Animals
  • Bacteria
  • Gastrointestinal Microbiome*
  • Inflammatory Bowel Diseases* / genetics
  • Inflammatory Bowel Diseases* / microbiology
  • Metagenomics
  • Mice
  • Microbiota*
  • Mycobiome* / genetics